The convergence of large complex data sets, scalable cloud compute infrastructure, artificial intelligence and better-defined security frameworks prompted us to develop these technologies into one platform. We realised that there was an opportunity to bring these technologies together alongside our expertise with the intention of helping organisations normalise and align genomics, phenotype and other health related data more efficiently and effectively.
Gareth has spent the last twenty years in the software and software security sectors. He’s held a variety of industry roles with organisations such as IBM, WhiteHat Security, Genomics Medicine Ireland and Progress Distribution, including Solution Architecture, Technology and Security Consulting, Business Development and Channel building.
Shubham specialises in Data Mining, Visual Analytics, Statistical Learning, Decision / Behavioural Analytics, Machine Learning and Artificial Intelligence. He has held a number of industry roles in the corporate Banking & Telecoms sectors.
Alex is a seasoned Senior Full Stack software developer with over ten years’ experience. Currently mainly focused on Python and React.js but has also a significant amount of C++ experience developing user-mode and kernel-mode OS components.
Sean is Director of the UCD Academic Centre of Rare Diseases (ACoRD) and cofounder of Genomics Medicine Ireland. He has life-long experience in research in medical genetics. Has established and led collaborative approaches to investigate chronic conditions such as Motor Neuron Disease (ALS), Autism Spectrum Disorder and Rare Diseases. He has extensive published research studies and is a frequent speaker in the area of genomics. Sean holds a PhD in genetics from University College Dublin and is a lecturer at the School of Medicine & Medical Sciences at UCD.
Maurice is Chief Commercial Officer & Co- Founder of Open Orphan. He is a serial entrepreneur having founded HiberGen, GMI & Open Orphan. Has significant C-level experience and been involved extensively in R&D investment, drug development, business strategy and business development with organisations such as GMI, HiberGen, Serono, Pfizer and ARCH Venture partners. He has also participated in securing global regulatory & market approval of 3 biologics at Serono and is an inventor on over 80 patents at the Genetics Institute/Pfizer.